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ABSTRACT A method is described for the exchange of native troponin of single rabbit psoas muscle fibers for externally
applied troponin complexes without detectable impairment of functional properties of the skinned fibers. This approach is
used to exchange native troponin for rabbit skeletal troponin with a fluorescent label (N-((2-(iodoacetoxy)ethyl)-N-methyl)
amino-7-nitrobenz-2-oxa-1,3-diazole, IANBD) on Cys133 of the troponin I subunit. IANBD-labeled troponin I has previously
been used in solution studies as an indicator for the state of activation of reconstituted actin filaments (Trybus and Taylor,
1980. Proc. Natl. Acad. Sci. USA. 77:7209–7213). In the skinned fibers, the fluorescence of this probe is unaffected when
cross-bridges in their weak binding states attach to actin filaments but decreases either upon the addition of Ca2 or when
cross-bridges in their strong binding states attach to actin. Maximum reduction is observed when Ca2 is raised to saturating
concentrations. Additional attachment of cross-bridges in strong binding states gives no further reduction of fluorescence.
Attachment of cross-bridges in strong binding states alone (low Ca2 concentration) gives only about half of the maximum
reduction seen with the addition of calcium. This illustrates that fluorescence of IANBD-labeled troponin I can be used to
evaluate thin filament activation, as previously introduced for solution studies. In addition, at nonsaturating Ca2 concen-
trations IANBD fluorescence can be used for straightforward classification of states of the myosin head as weak binding
(nonactivating) and strong binding (activating), irrespective of ionic strength or other experimental conditions. Furthermore,
the approach presented here not only can be used as a means of exchanging native skeletal troponin and its subunits for a
variety of fluorescently labeled or mutant troponin subunits, but also allows the exchange of native skeletal troponin for
cardiac troponin.
INTRODUCTION
Muscle contraction is thought to result from a cyclic inter-
action of the myosin heads with actin filaments. During this
cyclic action, the myosin heads alternate between two
classes of states (for reviews cf. Taylor, 1979; Eisenberg
and Hill, 1985; Hibberd and Trentham, 1986; Brenner,
1990). One class, in which cross-bridges make little contri-
bution to force generation, is characterized by low actin
affinity and little or no ability to activate thin filaments (cf.
Chalovich et al., 1983). The second class includes the main
force-generating states and is characterized by the potential
to bind to actin with high affinity and to activate the thin
filament. The ability to activate the thin filament is a par-
ticularly useful criterion for distinguishing the two classes
of states of the myosin head because this ability is largely
independent of the absolute binding affinity of the myosin
head for actin and therefore largely independent of ionic
strength (Chalovich et al., 1983). Instead, the potential to
enhance activation of the thin filament upon attachment of
myosin heads appears to depend on the difference in affinity
of the myosin head for the inactive versus active forms of
the actin filament, as discussed by Greene and Eisenberg
(1980) and Hill et al. (1981). One challenge in understand-
ing the molecular mechanisms of muscle contraction is to
determine how regulation of the thin filament, i.e., Ca2-
controlled movement of tropomyosin on the surface of the
actin filaments, affects the interaction of both weak and
strong binding states of the myosin head with the regulated
thin filament.
Possible approaches to these questions are the use of
fluorescent probes attached to regulatory proteins to moni-
tor the state of the thin filament and the use of mutants of
regulatory proteins generated by site-directed mutagenesis
and expressed and purified from suitable expression sys-
tems. Both approaches require extensive exchange of native
regulatory proteins, e.g., troponin and its subunits, for ex-
ternally applied fluorescently labeled or mutant proteins
with as little change as possible in the properties of the
skinned fibers.
Previously, protocols have been developed for the ex-
change of troponin C and troponin I by extraction, followed
by reconstitution with an externally applied protein (e.g.,
Zot and Potter, 1982; Moss et al., 1985; Babu et al., 1986;
Nakayama et al., 1990; Hatakenaka and Ohtsuki, 1991;
Strauss et al., 1992; Rarick et al., 1997). We set out to
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develop an approach that permits the introduction of any
troponin subunit or combination of troponin subunits into
single rabbit psoas muscle fibers while maintaining normal
fiber function. The approach used here is one of exchange
rather than extraction followed by reconstitution. This ap-
proach follows other observations that exchange processes
may be more efficient than protocols based on extraction
and subsequent reconstitution. For instance, we had ob-
served that M-line-associated, fluorescently labeled creatine
phosphokinase (CPK) is only slowly extracted (lost) from
skinned fibers under physiological and near-physiological
conditions, but is rapidly replaced (chased) when, under the
same conditions, skinned fibers are exposed to externally
applied, unlabeled CPK (Kraft et al., 1995b). This suggested
that molecules that can reversibly dissociate from their
binding sites can be replaced by externally applied mole-
cules that compete for the free binding sites.
Here we report the general approach to the exchange of
whole troponin and demonstrate its validity by introducing
N-((2-(iodoacetoxy)ethyl)-N-methyl)amino-7-nitrobenz-2-
oxa-1,3-diazole (IANBD)-labeled troponin I (TnI) into
skinned fibers of the rabbit psoas muscle. This probe was
previously used in solution studies to follow the state of thin
filament activation (Trybus and Taylor, 1980). The method
for the exchange of troponin, described here, is similar to
that described for the exchange of whole troponin in myo-
fibrils (Shiraishi et al., 1992). We show that the fluores-
cence of IANBD-labeled TnI can be used for straightfor-
ward classification of different states of the myosin head,
generated by the presence of different nucleotides or nucle-
otide analogs. A preliminary account of this work was
previously presented (Chalovich and Brenner, 1995; Bren-
ner et al., 1998).
MATERIALS AND METHODS
Preparation of proteins
Myosin (Kielley and Harrington, 1960), S1 (Weeds and Taylor, 1975),
actin (Eisenberg and Kielley, 1974), and tropomyosin-troponin (Eisenberg
and Kielley, 1974) were prepared from the back muscle of rabbits. Tro-
pomyosin was separated from troponin by hydroxyapatite chromatography
(Eisenberg and Kielley, 1974). The troponin was further purified by
chromatography on Cibacron blue, as described by Reisler et al. (1980).
Bovine cardiac troponin was prepared as described by Potter (1982).
Preparation of troponin with TnI
modified at Cys133
The troponin-tropomyosin complex was reduced at 30°C for 1 h in a
solution containing 100 mM KCl, 20 mM phosphate buffer (pH 6.5), 1 mM
EDTA, and 2 mM fresh dithiothreitol. After exhaustive dialysis against 30
mM KCl, 10 mM imidazole, 1 mM MgCl2, 1 mM EGTA, 0.1 mM
dithiothreitol, the sulfhydryl group of TnI was modified. Troponin-NBD
was prepared by reaction of a 1 mg/ml solution of tropomyosin-troponin
with a fivefold molar excess of IANBD (Molecular Probes, Eugene, OR)
in N,N-dimethylformamide. The mixture was incubated in the dark at 4°C
for 4 h, and the reaction was stopped with an excess of dithiothreitol.
Excess probe was removed by repeated dialysis. The same procedure was
used for the preparation of rhodamine-labeled troponin I, except that the
whole reduced troponin was treated with a fivefold molar excess of
rhodamine X-iodoacetamide (Molecular Probes). A slight amount of la-
beling of tropomyosin occurred under this condition. However, subsequent
to fluorescent labeling, the troponin complex was isolated by hydroxyap-
atite chromatography such that no tropomyosin was present in the final
product. A small amount of label was also incorporated into troponin C and
troponin T in some preparations. The labeling of these two subunits varied
from an undetectable level up to some 9% of the incorporation found in
troponin I.
Fiber preparation
Skinned fibers of rabbit psoas muscle were isolated and chemically skinned
with Triton X-100 as previously described (Brenner, 1983; Yu and Bren-
ner, 1989), but with the recent modification of adding several protease
inhibitors (for details see Kraft et al., 1995a). Single fibers were isolated as
previously described (Yu and Brenner, 1989), but within a few hours after
dissection of fiber bundles from the rabbit. Isolated single fibers were kept
for up to 5 days without a detectable loss of sarcomeric proteins, but with
the advantage of much improved diffusion of substrate and products. Some
experiments were performed with fibers isolated from fiber bundles that
had been frozen in liquid propane and stored in liquid nitrogen according
to our previously described procedures (Kraft et al., 1995b). No detectable
differences were found compared to fibers that were not subject to this
freezing, storage, and thawing procedure.
Solutions
All solutions were adjusted to pH 7.0 at the experimental temperature
(5°C). Chemicals were obtained from Sigma Chemie Mu¨nchen, FRG,
except when noted otherwise.
Skinning solution contained (in mM) 5.0 KH2PO4; 3.0 Mg-acetate; 5.0
EGTA; 1.0 Na2ATP (Merck, Darmstadt, Germany); 50 Na-creatine phos-
phate; 5.0 NaN3; 10 glutathione; 2.0 dithiothreitol; 0.1 4-(2-aminoethyl)-
benzenesulfonyl fluoride (Calbiochem-Novabiochem GmbH, Bad Soden,
Germany); 0.01 each of leupeptin, antipain, E64, and pepstatin; and 1
mg/ml aprotinin.
Preactivating and activating solutions contained (in mM) 10 imidazole,
2.0 MgCl2, 1.0 MgATP, 1.0–3.0 EGTA (or CaEGTA), 10 caffeine, and
500 U/ml (Sigma definition of units) of creatine kinase (Sigma, Mu¨nchen,
Germany). Ionic strength was adjusted by adding the appropriate amount of
sodium creatine phosphate, assuming a contribution to ionic strength of 3
mM/ mM of sodium creatine phosphate. The minimum concentration of
added creatine phosphate was 10 mM, resulting in 50 mM as the lowest
ionic strength for activation experiments.
Solutions of different pCa were obtained by mixing appropriate vol-
umes of preactivating and activating solutions.
Standard relaxing solution contained (in mM) 10 imidazole, 2.0 MgCl2,
1.0 MgATP, and 1.0 EGTA, resulting in a minimum ionic strength of 20
mM when no creatine phosphate was added.
Prerigor solution contained (in mM) 10 imidazole, 2.5 EGTA, and 15
EDTA.
Rigor solution was composed of (in mM) 10 imidazole, 2.5 EGTA, and
2.5 EDTA.
Mg-pyrophosphate (MgPPi) solution contained (in mM) 10 imidazole,
4.0 MgPPi, 2.0 MgCl2, 1.0 CaEGTA, and 0.2 Ap5A.
MgATPS-solution contained (in mM) 10 imidazole, 10 MgATPS,
2.0 MgCl2, 3.0 EGTA, 200 glucose, 0.5 U/ml hexokinase, and 0.2 Ap5A.
For all solutions, except skinning solution and preactivating and acti-
vating solutions, ionic strength was adjusted by adding appropriate
amounts of potassium propionate.
Exchange buffer contained (in mM) 20 3-(N-morpholino)propanesulfo-
nic acid, 5 MgCl2, 5 EGTA, 240 KCl, 5 dithiothreitol, and 7 g/ml
pepstatin (pH 6.5) at 20°C or 5°C.
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Quantification of troponin exchange
The exchange of intrinsic skeletal muscle troponin of skinned fibers for
cardiac troponin was determined by gel electrophoresis and Western blot
analysis. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) was done either with the PhastSystem (Pharmacia Fine Chemicals,
Uppsala, Sweden), using a 8–25% gradient of polyacrylamide, or on
minigels (Hoefer, San Francisco, CA), using 12% polyacrylamide gels.
The gels were stained with Coomassie brilliant blue. In some instances, the
electrophoresed proteins were blotted for 1 h at 24 V onto Immobilon
(Millipore, Bedford, MA) membranes, using a semidry blotter with the
buffer system of Towbin et al. (1979). The membranes were subsequently
blocked (5% powdered milk in Tris-buffered saline containing 0.01%
Tween 20) and then incubated with a mixture of monoclonal anti--actin
(Sigma Chemical Co., St. Louis, MO) and monoclonal anti-skeletal tropo-
nin I antibodies (Biodesign International, Kennebunk, ME). After washing
and incubation with the second antibody, the actin and skeletal troponin I
were visualized using enhanced chemiluminescence (Mathews et al.,
1985).
Experimental setup
The apparatus to record mechanical and fluorescent signals from segments
of skinned fibers was developed from the previously described experimen-
tal setup (Brenner, 1980; Brenner and Eisenberg, 1986). The setup was
fitted with a mercury arc lamp and an interference filter (Scientific Instru-
ments, Heidelberg, Germany) to select the proper wavelength for excitation
of IANBD fluorescence (486.1 nm, 11 nm bandwidth; Melles Griot, Irvine,
CA). The light of the mercury arc lamp was focused on the skinned fiber
by means of two cylindrical lenses to maximize the intensity of the exciting
light at the specimen. The emitted light was passed through a OG530 filter
with 50% transmission at 530 nm (Melles Griot). The binocular phototube
of a home-built inverted microscope could be replaced with an optical
device that imaged a section of the fiber on a photomultiplier tube (Sci-
entific Instruments, Heidelberg, Germany). The voltage of the photomul-
tiplier tube was set to obtain optimal signal-to-noise ratio, usually to some
1000 V. The bandwidth (3 dB) of the detection system was 2.4 kHz, with
a time constant of 80 s for the response to a step change in the intensity
output by 5 V, which is the upper limit for maximum fluorescence changes.
Confocal microscopy
Equilibration of skinned fibers with externally applied troponin was fol-
lowed by confocal microscopy to estimate the time required to reach
homogeneous troponin exchange across the fiber and to characterize the
labeling pattern within the sarcomeres. Because of the available laser
source for the excitation of fluorescence, we had to use rhodamine-labeled
troponin (Rh-TnI) instead of the IANBD-labeled troponin. To identify the
different structures within the sarcomeres, the M-line was selectively
stained by an antimyomesin antibody and a FITC-labeled secondary
antibody.
The system for confocal microscopy was previously described (Kraft et
al., 1995b) and consisted of a Zeiss Axiophot fluorescence microscope, a
Biorad MRC-600 confocal scanner, and a Silicon Graphics Personal Iris
4D/25 workstation. The system was equipped with an argon/krypton mixed
gas laser. The images were recorded using a Zeiss Planapochromat 40 
NA 1.0 oil immersion objective. Image processing was done on the Silicon
Graphics work station, using Imaris (Bitplane AG, Zu¨rich, Switzerland).
To follow equilibration by confocal microscopy, fibers were mounted in
a shallow slot-shaped chamber built on a microscope slide and closed with
a coverslip (cf. Kraft et al., 1995b).
The time course for the equilibration of fibers with troponin with the
TnI subunit labeled with rhodamine was quantitated as previously de-
scribed (Kraft et al., 1995b), e.g., by taking the ratio of intensity at
superficial areas over intensity in the fiber core seen in longitudinal
(optical) sections through the center of the fibers. The time course of
fluorescence decay as a measure of reexchange of rhodamine-labeled
troponin (rhodamine-labeled TnI subunit) for non-rhodamine-labeled tro-
ponin was followed in a similar way; longitudinal (optical) sections
through the center of the fibers were recorded (cf. Fig. 1), and intensity
profiles along a line perpendicular to the fiber axis (cf. white line in the
micrograph of Fig. 1) were plotted. To characterize the time course of
reexchange, the total integrated intensity of these profiles was plotted
against time (cf. Fig. 3 A).
Mechanical measurements
Isometric force and force redevelopment were recorded as previously
described (Brenner and Eisenberg, 1986). In short, after a period of
100–200 ms of unloaded or lightly loaded shortening, fibers were re-
stretched to their isometric sarcomere length to restore initial isometric
filament overlap. Fibers were then held at a fixed sarcomere length as
tension redeveloped from a low initial level of 10% of the isometric
steady-state force (cf. Brenner 1985).
X-ray diffraction experiments
Equatorial x-ray diffraction patterns were recorded by using the previously
described laboratory setup (Brenner et al., 1984). Integrated intensity, full
width at half-maximum, and position of the two innermost reflections (1,0
and 1,1 reflections) were determined after a linear background stripping as
previously described (Brenner et al., 1984). Exchange of native troponin
for Rh-labeled troponin (Rh-TnI) was performed according to the standard
protocol (see below) while the fibers were kept in the x-ray chamber.
Experimental protocol
Skinned fibers were attached to the force transducer and lever system of the
experimental setup, using a cyanoacrylate glue (Histoacryl; B. Braun
Surgical GmbH, Melsungen, Germany). The ends of the fibers were fixed
FIGURE 1 Experimental approach to characterizing the change in fluo-
rescence when fluorescently labeled troponin (Rh-labeled troponin I sub-
unit) is “chased” with troponin that is “invisible,” with the rhodamine
excitation-emission system of the confocal laser scanning microscope (e.g.,
troponin with IANBD-labeled troponin I subunit). (Left) Segment of a
longitudinal optical section through the center of a skinned fiber. (Right)
Intensity profile recorded along the line across the fiber, as indicated by
white line in the segment of the longitudinal section. To obtain this profile,
10 profiles within the area of the white line, each one pixel wide, were
averaged to reduce intensity fluctuations due to cutting through different
parts of the sarcomeres and thus through different labeling densities. The
total area under such profiles was determined and plotted versus time to
follow the loss of fluorescently labeled troponin over time.
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with glutaraldehyde according to the method of Chase and Kushmerick
(1988), with some modifications (Kraft et al., 1995a).
After mounting and setting the sarcomere length at 2.3–2.4 m, iso-
metric force and force redevelopment were recorded under various levels
of Ca2 activation. Subsequently, TnI was exchanged for IANBD-labeled
TnI by exchange of the whole troponin complex. For the exchange process,
fibers were put into rigor via prerigor solution (Brenner et al., 1982, 1986)
at 5°C. After several thorough washes to remove traces of ATP, fibers were
transferred into exchange buffer containing 0.3–1.5 mg/ml of skeletal
troponin with the IANBD-labeled TnI (unless otherwise stated), and the
temperature was raised to 20°C. In some experiments, the temperature for
exchange was kept at 5°C, resulting in no detectable difference compared
with exchange at higher temperature, except for the need for a somewhat
longer time for reaching maximum exchange. After exchange periods
ranging from 2 to 12 h, unbound troponin was removed by washing the
fibers in several changes of exchange buffer without IANBD-labeled
troponin for at least 30 min. After this washing period, IANBD fluores-
cence and mechanical parameters were recorded under the various exper-
imental conditions. During Ca2 activation fibers were permanently cycled
between isometric steady-state contraction and short (150–200 ms) periods
of lightly loaded or unloaded shortening with subsequent restretch to the
initial (isometric) sarcomere length. Repeating this maneuver every 5 s
stabilized the striation pattern during prolonged activation (Brenner, 1983).
RESULTS
Exchange of native troponin for troponin with
fluorescently labeled TnI
Exchange studied by PAGE
Quantification of the exchange of native troponin for exter-
nally applied fluorescently labeled troponin was achieved
by PAGE and Western blot analysis. However, to differen-
tiate native material from exchanged material, we had to use
cardiac troponin for exchange. Both cardiac troponin I (TnI)
and troponin T (TnT) are larger than their skeletal counter-
parts (Hatakenaka and Ohtsuki, 1991), such that TnI and
TnT of both sources can be separated by SDS-PAGE. Fig.
2 A shows that under several conditions of exchange (varied
length of exchange time and troponin concentration) a high
level of exchange can be achieved. Fig. 2 A (lanes a and b)
shows the presence of cardiac troponins I (cTnI) and T
(cTnT) in the exchanged fibers. Troponin C was not re-
solved well enough to confirm that this component is also
exchanged. However, other data indicate the exchange of
troponin C by this method. For instance, the force-pCa
relation of rabbit psoas fibers changed to that characteristic
of cardiac troponin C when the exchange was made with
bovine cardiac troponin (cf. Fig. 2 B). Because skeletal TnI
(sTnI) comigrates with light chain 1 (LC1), it is unclear
whether sTnI is still present after the “exchange” procedure.
Lanes c and d, however, show that after incubation for 6 h
with 3 mg/ml of cardiac troponin, the original skeletal
troponin I is no longer detectable by Western blot analysis.
Yet fibers are still fully Ca2-regulated; that is, they are
fully relaxed at low Ca2 and generate tension when Ca2
is raised (cf. Fig. 2 B). This indicates that there is real
exchange and not simply adsorption of additional troponin.
Lanes e–h demonstrate that troponin T is also exchanged by
this method. Lanes e and f were run in the absence of urea.
Under these conditions, the skeletal troponin T comigrates
with tropomyosin. While the addition of cTnT to the fibers
can be seen (Fig. 2 A, lanes e and g), it is not clear how
much of the skeletal troponin T had been removed. There-
fore, lanes g and h were run in the presence of 8 M urea in
the sample. Under these conditions, tropomyosin comi-
FIGURE 2 (A) SDS-polyacrylamide gels of fibers after the exchange of
endogenous troponin for cardiac troponin under different conditions. Only
those parts of the gels containing troponin are shown. Lanes a, b, c, and d
were run to emphasize the exchange of cTnI for sTnI. Lanes a (control) and
b (3 h of exchange with 0.5 mg/ml cardiac troponin, 5°C) are from 12%
polyacrylamide gels stained with Coomassie blue. Lanes c (control) and d
(6 h of exchange with 3 mg/ml cardiac troponin, 5°C) are Western blots of
10% polyacrylamide gels probed with an antibody selective for sTnI. Lanes
e, f, g, and h were run to emphasize that sTnT also is exchanged for cTnT.
The fibers were incubated with 2.5 mg/ml cardiac troponin for 17 h at 5°C.
Lanes e and g are from exchanged fibers, and f and h are controls. Lanes
e and f were run in normal fashion, and the tropomyosin co-migrated with
the sTnT. Lanes g and h were run in a buffer containing 8 M urea in
addition to the SDS. In that case, the tropomyosin comigrated with the
actin, and the sTnT can be seen more readily. (B) Force-pCa relations
recorded before (f) and after () 8 h of incubation in exchange buffer with
2.5 mg/ml of cardiac troponin. Note the much shallower force-pCa relation
after incubation. This is similar to the change reported upon partial extrac-
tion of TnC from skeletal fibers followed by substitution with cardiac TnC
(Moss et al., 1986).
2680 Biophysical Journal Volume 77 November 1999
grates with actin. It can be seen that skeletal TnT is no
longer present in the exchanged fibers (lane g). This is
further evidence for true exchange and shows that at 5°C
within 6 h of incubation with 3 mg/ml of cardiac troponin,
exchange for cardiac troponin is essentially complete, as
confirmed after 17 h of incubation at 5°C with 2.5 mg/ml.
It should be noted that the use of cardiac troponin instead of
skeletal troponin may have required longer times to achieve
maximum exchange than necessary for skeletal troponin.
Confocal microscopy
To follow exchange in real time, using skeletal troponin
instead of the cardiac troponin, and to examine the local
distribution of exchanged troponin within the fiber cross
section and within the sarcomeres, we used confocal laser
scanning microscopy. We had to use skeletal troponin with
rhodamine-labeled TnI because no suitable laser source was
available to excite the IANBD fluorescence in the confocal
laser scanning microscope.
The time course of equilibration of fibers with fluores-
cently labeled troponin and the labeling pattern at the sar-
comere level are shown in Fig. 3. In Fig. 3 A three longi-
tudinal optical sections through the core of a fiber are shown
that were recorded after 7, 37, and 260 min of incubation
with 0.3 mg/ml of Rh-TnI-containing troponin. Note that
the images after 7 and 37 min show lower intensity in the
core of the fiber. This is no longer present in the third image
FIGURE 3 Labeling pattern and time course of equilibration followed by confocal microscopy. (A) Time course of equilibration with fluorescently
labeled troponin (Rh-troponin-I) after 7, 37, and 260 min of incubation in exchange buffer with 0.3 mg/ml Rh-labeled troponin. To identify the M-line
within the sarcomeres, the image taken after 260 min shows the fluorescence of Rh-labeled troponin I (right) and the fluorescence of a FITC-labeled
antimyomesin antibody (left; cf. Kraft et al., 1995b). Corresponding M-line positions are indicated by arrows. A1: Chase of fluorescently labeled troponin
(rhodamine-labeled troponin I subunit) by incubation in exchange buffer with 0.3 mg/ml of IANBD-labeled troponin (E). To achieve preexchange of native
troponin for Rh-TnI-troponin, the fiber was incubated for 2.5 h in 0.3 mg/ml troponin with rhodamine-labeled TnI. Upon incubation with exchange buffer
containing the IANBD-labeled troponin, the Rh fluorescence changed with a half-time of 20 min. Control after 12 h gives the final lower limit of
fluorescence (background level). Incubation in exchange buffer without any troponin results in only marginal loss of fluorescence over the same 12-h period
(f). Solid lines are fits of exponential functions to the data points (modified from Kraft et al., 1995c). (B) The labeling pattern for short and long sarcomere
lengths. The sarcomere length of the two fibers was first set at 2.31 and 3.13 m, respectively. Then exchange was initiated by incubation for 2 h in
exchange buffer with 0.3 mg/ml of rhodamine-labeled troponin (Rh-labeled TnI subunit). Arrows indicate the M-line, as identified by FITC-labeled
antimyomesin antibody (cf. a). Note that fluorescence labeling 1) is highest in the area that correlates with overlap between actin and myosin filaments,
2) is reduced in the I-band part of the actin filaments, and 3) at long sarcomere lengths appears even lower in the H-zone.
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recorded after 260 min, indicating still incomplete equili-
bration after 37 min. In the third image both fluorescence of
Rh-labeled TnI and that of a FITC-labeled secondary anti-
body against an antimyomesin antibody are shown to iden-
tify the M-lines (equivalent structures are indicated by
arrows).
To better establish the time required for the exchange of
troponin, we examined the time course of reexchanging the
fluorescently labeled TnI for unlabeled TnI, because it is
easier to detect the approach to background-level intensity
rather than to a maximum that is difficult to predict because
it varies, e.g., with the geometry of the experimental ar-
rangement, like fiber diameter and thus the position of the
optical section within the fiber. This is because fibers are
thick specimens (on the order of 100 m), such that ab-
sorption of exciting and emitted light within the fiber and
defocusing due to optical aberrations and inhomogeneities
are significant. It is therefore expected that maximum in-
tensity in an optical section through the core of a fiber will
vary, depending on fiber diameter, even when full exchange
of troponin for fluorescently labeled troponin is achieved.
To characterize the time course of reexchange of fluores-
cently labeled troponin for unlabelled troponin, fibers that
had first incorporated the rhodamine-labeled troponin (Fig.
3 A) were incubated in exchange buffer with troponin con-
taining IANBD-labeled troponin I, which is not “visible” in
the confocal microscope with the excitation/emission sys-
tem for rhodamine. Fig. 3 A1 (open circles) shows that
during such a chase experiment, fluorescence decayed to
20% within 50–80 min. After 15 h, the remaining fluo-
rescence was 2%, i.e., the exchange was essentially com-
plete. Note that over the same period of incubation in
exchange buffer without the IANBD-labeled troponin, only
a small decrease in fluorescence occurred (filled squares).
This indicates that the decay in fluorescence in the chase
experiment results from the exchange of Rh-labeled TnI for
the “nonvisible” IANBD-labeled TnI and is not due to
spontaneous loss of TnI from the fibers. Effects from
bleaching during the test scans with the confocal laser
scanning microscope were ruled out by comparison with
other areas of the fibers that were not scanned before. The
time course of this “chase experiment” agrees well with the
exchange followed by PAGE analysis (Fig. 2). Note, how-
ever, that with cardiac troponin, used for the PAGE analy-
sis, somewhat longer times might be required for complete
exchange of the native skeletal troponin.
To determine whether the total intensity reported by
imaging the fiber onto the photomultiplier device follows a
time course similar to the equilibration followed by confo-
cal microscopy, we fitted our confocal scanner directly to
the home-built inverted microscope. Using a 20 water
immersion objective (Achroplan 20/0.50 w; Carl Zeiss,
Jena, Germany), we could record confocal images while the
fibers were mounted in our mechanical setup. After slight
differences over the first few minutes, the time course of
total intensity of photomultiplier output and the time course
of integrated intensity within profiles across a longitudinal
section through the core of the fiber by confocal imaging
(cf. Fig. 1) were essentially identical.
Fig. 3 B shows the labeling pattern of two fibers that were
incubated at two different sarcomere lengths. Both fibers
were incubated for 2 h in exchange buffer with 0.3 mg/ml of
troponin with Rh-labeled TnI. Note that the labeling of the
thin filament is not homogeneous throughout its whole
length, but rather appears to be more prominent within the
area of overlap between thick and thin filaments. For the
procedure for identifying the various elements of the sarco-
mere, see Fig. 3 A (arrows indicate the M-line position).
The localization of fluorescence to the area of overlap again
indicates that fluorescent troponin is not just binding to the
actin filament nonspecifically, but that instead true ex-
change occurs, which is promoted by strongly attached
cross-bridges. This is supported by the observation that
under relaxing conditions (no attachment of cross-bridge in
strong binding states) no substantial exchange could be
achieved (data not shown). The apparent preferential ex-
change of troponin within the overlap region is in contrast to
the extraction of troponin C, which appears to occur pref-
erentially in the nonoverlap region (Yates et al., 1993),
while the rebinding of troponin C to myofibrils that had
been extracted to remove virtually all of the troponin C did
occur primarily in the overlap region (Swartz et al., 1997).
Thus it appears that strong cross-bridge attachment affects
exchange by the various procedures in different ways.
Equatorial x-ray diffraction patterns
Widths and intensities of the two innermost equatorial re-
flections (1,0 and 1,1 reflections) of x-ray diffraction pat-
terns are sensitive to both disorder in the myofilament
lattice and addition of mass to the thin filament (Haselgrove
and Huxley, 1973; Yu et al., 1985). Thus recording of
equatorial diffraction patterns allowed us to test whether our
exchange protocol had affected the submicroscopic struc-
ture of skinned fibers, as we had seen before when using the
standard protocols for extraction/reconstitution of troponin
C (TnC) (e.g., Zot and Potter, 1982; Moss et al., 1985; Babu
et al., 1986; our own unpublished results). After incubation
for 2 h in exchange buffer with 0.5 mg/ml of Rh-labeled
skeletal troponin (Rh-labeled TnI incorporated into tropo-
nin), after which time 80% of native troponin is expected
to be replaced by externally applied troponin (cf. Fig. 3 A1),
there was no detectable change in the equatorial diffraction
pattern, e.g., in the widths or intensities of the two inner-
most reflections. In fact, the patterns before and after ex-
change were indistinguishable (Fig. 4). This indicates that
no detectable structural disorder is introduced by the ex-
change protocol and that no detectable amount of additional
mass becomes associated with the thin filaments during the
incubation period. That significant incorporation of rho-
damine-labeled TnI had been accomplished during these
test incubations was verified by confocal microscopy, the
reason for using Rh-labeled troponin (Rh-TnI) in this con-
trol study.
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Mechanical properties before and after exchange
of native troponin for fluorescently
labeled troponin
To test whether the exchange of endogenous troponin for
IANBD-labeled troponin changes the normal function of the
skinned fibers, we examined active force and the rate con-
stant of force redevelopment at maximum and submaximum
Ca2 (Fig. 5). At saturating Ca2 concentrations active
tension and the rate constant of force redevelopment were
reduced by less than 5% and 10%, respectively, after the
exchange procedure (Fig. 5 a). The procedure also had little
if any effect on force-pCa relations and plots of kredev versus
force (Fig. 5, b and c), suggesting that there was no signif-
icant loss of, e.g., troponin C during our exchange protocol.
IANBD fluorescence in different states:
reconstituted versus native thin filaments
Previous solution studies showed that for reconstituted thin
filaments the fluorescence of IANBD-labeled TnI is de-
creased by Ca2 binding to TnC or by attachment of myosin
subfragment 1 in a strong-binding state (Trybus and Taylor,
1980). We therefore compared the behavior of IANBD-
labeled TnI in response to Ca2 and attachment of cross-
bridges in strong binding states to reconstituted actin in
solution with the behavior of IANBD-TnI fluorescence after
exchanging the labeled troponin complex into native thin
filaments of the skinned fibers.
FIGURE 4 Equatorial diffraction patterns recorded before and after 3 h
of incubation in exchange buffer with 0.5 mg/ml of rhodamine-labeled
troponin (Rh-labeled TnI). Note there is no significant change in the
equatorial intensities (I1,0 and I1,1), the width of the reflections, or
background scatter; i.e., the two patterns are essentially indistinguishable.
FIGURE 5 Mechanical parameters before and after exchange of endog-
enous troponin for fluorescently labeled troponin (IANBD-labeled TnI-
subunit). (a) Isometric force and rate constant of force redevelopment
(kredev) at saturating Ca
2 concentrations. Data of three fibers, means 
SD. (b) Force-pCa relations. F, Before exchange; E, after exchange. Solid
lines are fits of the sigmoidal function to data points (means  SD). Note
that even at low activation levels there is no significant change in the
force-pCa relation, indicating that full regulation is preserved. (c) Force
versus kredev for different degrees of Ca
2 activation. F, Before exchange;
E, after exchange.
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Solution studies
Fig. 6 is a summary of several solution measurements of
fluorescence changes of IANBD-TnI in response to Ca2
and S1 binding in the absence of nucleotide. The fluores-
cence in the absence of Ca2 and S1 was defined as 1.0,
while the lowest value of fluorescence in a particular series,
i.e., in the presence of both Ca2 and S1, was defined as
zero. Note that in the figure, values of zero were offset by
0.015 for clarity. Measurements were made at both 56 mM
and 155 mM ionic strength. The addition of Ca2 alone
caused a reduction in fluorescence by, on average, 84% of
the maximum change in fluorescence. However, note that in
two out of seven trials Ca2 alone also resulted in the
maximum possible inhibition of fluorescence. The addition
of saturating amounts of S1, in the absence of free Ca2,
reduced the fluorescence by only 52% of the maximum
change, i.e., less than that seen with Ca2 alone. The
fluorescence was reduced to its minimum value in the
presence of both Ca2 and S1. Using the same probe,
Trybus and Taylor observed that at 220 mM ionic strength,
Ca2 alone caused 80% of the total change seen in the
presence of both S1 plus Ca2, while at 20 mM ionic
strength Ca2 alone caused only one-third of the total effect.
The results at 220 mM ionic strength are similar to ours in
that respect. Trybus and Taylor also found that either Ca2
alone or S1 alone gave 80% of the total change, whereas,
in our hands, S1 alone gives only50% of the total change.
The difference between our preparation of IANBD-troponin
and theirs is that subsequent to labeling we removed tropo-
myosin from the fluorescently labeled troponin by hydroxy-
apatite chromatography and reconstituted with unmodified
tropomyosin. Normally 10% of the tropomyosin was la-
beled during reaction of the troponin-tropomyosin complex
with IANBD. In heavily labeled preparations, up to 10%
of the total label was on troponin C and a trace amount was
on troponin T. The variation in the labeling of TnC may
contribute to the differences observed. The labeling of TnC
and the trace labeling of TnT are not easily observable, and
there is no way of knowing the extent to which this was a
factor in other laboratories using this same labeling procedure.
Skinned fiber studies
Effect of weak binding states of the myosin head
The effect of actin interaction of weak binding states of the
myosin head on the fluorescence of IANBD-labeled TnI
was examined for relaxed fibers (low Ca2) in the presence
of MgATP and in the presence of the nucleotide analog
MgATPS. MgATPS is a slowly hydrolyzed ATP analog
(Goody and Eckstein, 1971) for which the elementary cleav-
age step is 500-fold slower than for MgATP (Bagshaw et
al., 1973). In fibers, the rate of MgATPS hydrolysis is not
affected by Ca2 (Dantzig et al., 1988; Kraft et al., 1992).
We previously showed that cross-bridges with MgATPS
cannot activate the thin filament (Kraft et al., 1992; Resetar
and Chalovich, 1995); i.e., cross-bridges with ATPS in the
nucleotide binding site represent weak binding states of the
myosin head. As shown in Fig. 7 b, at low Ca2 concen-
tration, IANBD fluorescence is essentially the same in the
presence of MgATP or MgATPS. Moreover, when ionic
strength is lowered in the presence of MgATP under relax-
ing conditions, no change in fluorescence is seen (Fig. 7 c),
despite an increasing number of myosin heads in weak
binding states becoming attached to actin (cf. Brenner et al.,
1984, 1986).
Effect of Ca2 in the presence of MgATP or
MgATPS. Raising Ca2 to saturating levels (pCa 4.5)
results in a quenching of fluorescence by some 50%, not
only in the presence of MgATP (Fig. 7), when fibers are
generating full isometric tension, but also in the presence of
MgATPS (Fig. 7 b), where fibers do not generate any
detectable active force (1–2% of the maximum isometric
force that would be our detection limit). This indicates that
at saturating Ca2 concentrations maximum inhibition is
observed irrespective of the presence (MgATP) or absence
(MgATPS) of cross-bridges in their strong binding states,
as has also been described meanwhile for probes on TnC
(Martyn et al., 1999).
In solution, the magnitude of the fluorescence change of
IANBD-labeled troponin upon activation with both a high
Ca2 concentration and S1 binding was previously reported
to be relatively insensitive to ionic strength. In contrast, the
FIGURE 6 IANBD-troponin fluorescence under different conditions in
solution. Each bar represents a separate measurement of fluorescence with
excitation at 492 nm and emission at 538 nm. Conditions: 3.5 M actin, 0.6
M troponin-tropomyosin, and either 0 or 3.5 M myosin subfragment 1
(S1) at 10°C in a final volume of 2.86 ml of 20 mM imidazole, pH 7.0, 2
mM MgCl2, either 34 mM () or 134 mM potassium propionate (f) and
either 2 mM EGTA or 2 mM CaEGTA. The troponin was labeled on the
TnI subunit with IANBD. The fluorescence was first measured in the
absence of Ca2 and then again on the same sample after the addition of
CaCl2. For ease of comparison, the data were normalized such that fluo-
rescence in the absence of both Ca2 and S1 was set at 1.0, while the
lowest fluorescence value in any single experiment (in the presence of
Ca2 and S1) was defined as zero. Fluorescence was normalized so that
experiments done with different protein preparations could be compared.
The actual decrease in fluorescence was 16%. Note that fluorescence of
the free troponin-tropomyosin complex is only about half the fluorescence
of the troponin-tropomyosin complex bound to actin and does not change
when the Ca2 concentration is altered. Thus, for 0.1 M of free troponin-
tropomyosin complex, at most 10% of total fluorescence seen in the
absence of Ca2 is Ca2-insensitive fluorescence originating from the free
troponin-tropomyosin complex.
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fraction of the total fluorescence change due solely to the
addition of Ca2 increased with increasing ionic strength
(Trybus and Taylor, 1980). To determine the ionic strength
effect on the fluorescence change upon the addition of Ca2
in fibers, it was necessary to stretch the fibers out of
filament overlap to avoid attachment of cross-bridges in
strong binding states in the presence of MgATP when Ca2
was raised. Simple replacement of ATP with ATPS could
have been used as an alternative method to prevent active
cross-bridge turnover with the attachment of cross-bridges
in their strong binding states at high Ca2 concentrations.
However, the 10 mM MgATPS needed for full nucleotide
saturation at high Ca2 concentrations (Kraft et al., 1992)
would have precluded extending the ionic strength depen-
dence to values below 63 mM.
Table 1 shows that there is no statistically relevant (p 
0.05) effect of ionic strength on the inhibition of fluores-
cence by Ca2 alone. In the fiber, as also seen for two out
of seven trials in solution, Ca2 alone gives the maximum
fluorescence change with little additional effect by attach-
ment of myosin heads in their strong binding states (Fig. 7
b, ATPS Ca2 versus ATP Ca2, or MgPPi and rigor
at high Ca2; see next paragraph). Furthermore, in our
solution studies, unlike the earlier report of Trybus and
Taylor (1980), there is little effect of ionic strength on the
maximum change in fluorescence.
Fluorescence in rigor and in the presence of 4 mM
MgPPi. At saturating Ca
2 concentrations, the fluores-
cence in rigor and in the presence of 4 mM MgPPi is
reduced to essentially the same level as seen at saturating
Ca2 concentrations in the presence of MgATP or
MgATPS. However, in the absence of Ca2, the fluores-
cence of fibers in rigor or in the presence of 4mM MgPPi is
intermediate between that of relaxed fibers and the fluores-
cence at saturating Ca2 concentrations (Fig. 7 b).
It is conceivable, however, that the inhibition of fluores-
cence with the attachment of cross-bridges in their strong
binding states (MgPPi, rigor) is an indirect effect resulting
from an increased Ca2 affinity of TnC. In that case the
effect of strong cross-bridge attachment to actin when no
Ca2 is added to the solutions results from increased bind-
ing of contaminant Ca2 to the regulatory proteins. To
clarify this question we studied the effect of Ca2 titration
on the IANBD-TnI fluorescence in rigor, where all cross-
bridges occupy the strong-binding-type rigor state. If attach-
ment of cross-bridges in their strong binding states has a
direct inhibitory effect, then as free Ca2 is lowered, fluo-
rescence should not reach the relaxed level, but rather a
Ca2-independent level between the fully activated (high
Ca2) level and the fully relaxed (low Ca2) level in the
presence of ATP or ATPS values. As shown in Fig. 8, as
Ca2 concentration is lowered, IANBD fluorescence under
rigor conditions approaches a Ca2 independent level that is
significantly lower than the relaxed level (filled triangle)
and about half way between relaxed and fully Ca2-satu-
rated levels. Note that for fibers out of overlap (i.e., without
cross-bridge attachment), fluorescence is independent of
nucleotide (cf. open triangle versus open circle at low Ca2
concentration), and the fluorescence-pCa relation is shifted
by about an order of magnitude to higher Ca2 concentra-
tions. This observation suggests that actin interaction of
cross-bridges in their strong binding states both inhibits
IANBD-TnI fluorescence directly and shifts the fluores-
cence-pCa relation to lower Ca2 concentrations, presum-
ably by increasing the Ca2 affinity of TnC. Other factors
FIGURE 7 IANBD fluorescence observed in skinned fibers under dif-
ferent experimental conditions. (a) Fluorescence intensity in the presence
of MgATP at low (pCa8; f) and high (pCa 4.5;) Ca2 concentrations.
The data are from six fibers; data were normalized to the average intensity
recorded under relaxing conditions (means  SD). (b) Effect of Ca2 at
different nucleotide conditions. Here the change in fluorescence with the
addition of Ca2 is normalized to the maximum change between highest
fluorescence (ATP, no Ca2) and minimum fluorescence (ATPS 
Ca2). To show the lowest level, the data for ATPS  Ca2 are offset by
0.015. The data of six fibers are summarized; data are means  SD. Note
that two extreme levels of fluorescence are observed, one in the absence of
Ca2 when cross-bridges are detached or only weakly bound to actin (low
Ca2, with MgATPS or MgATP). The other level is seen in the presence
of saturating Ca2 when cross-bridges are attached to actin in either their
strong binding states (MgPPi, rigor) or their weak binding states
(MgATPS), or both (MgATP). An intermediate level is observed when
cross-bridges in their strong binding states attach to actin in the absence of
Ca2 (MgPPi, rigor). (c) Effect of ionic strength under relaxing conditions.
Each symbol represents an individual fiber (total of five fibers).
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associated with stretching fibers out of overlap, like changes
in lattice spacing or some loss of TnC when exchanging at
long sarcomere lengths, however, might also contribute to
the shift in the fluorescence-pCa relation.
Nevertheless, these data indicate that the IANBD probe
on troponin I, in principle, is sensitive to activation of thin
filaments by calcium and by actin attachment of cross-
bridges in their strong binding states, although the magni-
tude of the change is different in the two cases (Fig. 7).
Note, however, that attachment of cross-bridges in their
strong binding states in addition to saturating Ca2 concen-
tration does not further reduce fluorescence (Fig. 7 b), in
contrast to the biochemical studies in solution (Trybus and
Taylor, 1980; Fig. 6, but also note that two trials in our
solution studies also gave full inhibition by calcium alone).
IANBD fluorescence at different degrees of Ca2 activa-
tion. Next we characterized the relation between IANBD-
TnI fluorescence and the level of Ca2 activation in the
presence of ATP, i.e., with active cross-bridge turnover
(Fig. 9). To characterize the contribution from force-gener-
ating cross-bridges we first recorded IANBD fluorescence
in full overlap (open squares). Then fibers were stretched
out of filament overlap and fluorescence was recorded again
at different degrees of Ca2 activation (open circles). The
lower fluorescence intensities at long sarcomere length are
due to fewer sarcomeres (i.e., fewer fluorophores) in the
field of view. In full overlap, the relation between IANBD
fluorescence and pCa appears to be shifted toward lower
Ca2 concentrations compared to the out-of-overlap condi-
tion. This becomes more evident in Fig. 9 b, where fluores-
cence data for both long and short sarcomere lengths were
normalized to their respective values under relaxing condi-
tions. The shift to lower Ca2 concentrations and the some-
what steeper pCa-relation suggests some contribution to the
change in fluorescence by force-generating, strong binding
cross-bridges, at least at nonsaturating Ca2 concentrations.
From all fibers studied, the inhibition of fluorescence upon
maximum Ca2 activation (pCa 4.5) was 46 10% (n	 6)
in full overlap versus 44  6% (n 	 4) out of overlap. This
suggests that at saturating Ca2 concentrations actin attach-
ment of endogenous cross-bridges that occupy strong bind-
ing states has little additional effect on the reduction of
fluorescence, which is consistent with the rather similar
fluorescence observed under any nucleotide condition at
high Ca2 concentrations (cf. Fig. 7 b). A similar observa-
tion with probes on TnC has recently been described by
Martyn et al. (1999).
DISCUSSION
The present study shows that whole troponin can be ex-
changed into skinned fibers of rabbit psoas muscle without
detectable alteration of their mechanical and structural prop-
erties. This procedure allows the incorporation of alterna-
tive types of troponin, such as cardiac troponin, as well as
modified skeletal troponins such as the fluorescently labeled
troponin used here. Gel electrophoresis was used to verify
that troponin I and troponin T are exchanged. Exchange
instead of unspecific binding is also demonstrated by the
change in the force-pCa relationship that occurred when the
native skeletal muscle troponin was exchanged for cardiac
troponin. Confocal microscopy also verified exchange by
showing that the fluorescent troponin is preferentially lo-
cated in the region of filament overlap.
The exchange procedure apparently does not degrade
structural or functional properties of the fibers. 1) The
equatorial reflections of x-ray diffraction patterns are un-
changed after incorporation of externally applied troponin.
Changes in intensities or widths of reflections would have
occurred if there had been significant structural changes. 2)
Isometric force, force redevelopment, and force-pCa rela-
tions are virtually unchanged after the exchange procedure.
This is a significant improvement over other methods that
we have tried that are based on the extraction of TnC
followed by reconstitution (Zot and Potter, 1982; Moss et
al., 1985; Babu et al., 1986). These previously developed
methods did not give as great an extent of exchange; the
force is not fully restored after reconstitution, especially
when the extent of exchange is maximized. In addition,
equatorial diffraction patterns suggested significant struc-
tural disorder (own unpublished observations). One method
that we have not tested involves the extraction of TnI and
TnC with an excess of TnT (Nakayama et al., 1990; Shi-
raishi et al., 1992; J. Potter, personal communication).
The structural and functional preservation during our
exchange process may be due to the near-physiological
conditions for the exchange and the avoidance of unpaired
protein interactions. The exchange process used here re-
quires reversible dissociation of regulatory proteins or parts
of the native regulatory protein complexes. Under normal
conditions the detached proteins or detached parts of the
native complexes rebind rapidly to unoccupied binding
sites, and diffusion of these proteins out of the highly
condensed structure of skinned fibers cannot effectively
occur unless the binding affinity is drastically lowered by
TABLE 1 Inhibition of IANBD fluorescence by Ca2 for fibers stretched beyond filament overlap
Ionic strength 20 mM 50 mM 100 mM 170 mM
Inhibition of fluorescence 0.78 0.12 0.84  0.05 1.00  0.05 0.81  0.03
After exchange of native troponin for IANBD-labeled troponin at sarcomere lengths between 2.3 and 2.4 m, fibers were stretched to sarcomere lengths
where no overlap between actin and myosin filaments can occur (sarcomere length 4.2 m). The observed extent of reduction in fluorescence at saturating
Ca2 concentrations is normalized to the maximum reduction that was seen at 100 mM ionic strength. Numbers are means  SD, n 	 3. SD for 100 mM
results from taking the average of all measurements at 100 mM ionic strength as 1.0 and calculating the SD from the scatter of the individual measurements
around the mean. Note that the effects of Ca2 on the magnitude of the fluorescence changes are not statistically different (p  0.05) at the different ionic
strengths examined. At 100 mM ionic strength the decrease in fluorescence with the addition of Ca2 was 20 2% of the fluorescence observed at low Ca.
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imposing highly nonphysiological conditions. In the case of
an exchange reaction, however, sites that become tran-
siently unoccupied under near-physiological conditions are
rapidly filled by competition with externally applied mole-
cules (cf. Kraft et al., 1995b).
Because exchange occurs preferentially in the region of
overlap, it is necessary to exert care when interpreting
experiments specifically when the sarcomere length is
changing. For instance, if the exchange is not uniform along
the length of the thin filament, then as the fiber shortens,
some cross-bridges may move into an unlabeled region of
the actin filament. In this case, cross-bridges that contribute
to the mechanical properties of the fiber will be invisible in
terms of fluorescence changes. This problem can be avoided
by measuring the sarcomere length during labeling and
during experimentation. It is not likely that the nonex-
changed parts of the thin filaments in the I-band will com-
plicate the fiber behavior as a result of cooperative effects
along the thin filaments. In fibers and myofibrils these
cooperative effects appear to be limited to rather short
distances (cf. Swartz et al., 1990; Kraft et al., 1995b).
IANBD-fluorescence is sensitive to both actin
interaction of cross-bridges in strong binding
states and Ca2 binding to troponin C
Our data show that in fibers, as in solution, both an increase
in Ca2 and actin interaction of cross-bridges in their strong
binding states reduce the fluorescence of IANBD-labeled
troponin I. In fibers, Ca2 alone (no attachment of cross-
bridges in strong binding states, e.g., in the presence of
MgATPS) results in maximum inhibition of fluorescence,
while attachment of cross-bridges in strong binding states
alone (rigor cross-bridges and cross-bridges with MgPPi at
relaxing Ca2 concentration) results in only half-maximum
fluorescence change. Studying the effect of different Ca2
concentrations on IANBD-TnI fluorescence in the presence
of cross-bridges in strong binding states (e.g., in rigor)
suggests that the inhibition of fluorescence in this condition
results directly from actin interaction of cross-bridges in
strong binding states and not just from increased Ca2
affinity of troponin C (cf. Fig. 8).
There are two differences between the changes seen in
fibers with changes reported earlier with IANBD-labeled
TnI in solution (Trybus and Taylor, 1980). First, in fibers
maximum fluorescence change was already seen upon the
addition of calcium alone, whereas in solution, 80% of
fluorescence change occurred with calcium alone and addi-
tional strong cross-bridge attachment was required for max-
FIGURE 8 Effect of different Ca2 concentrations under rigor condi-
tions in full filament overlap (SL 	 2.4 m; f) and when fibers were
stretched beyond filament overlap (SL  4.2 m; E). Œ, ‚, Fluorescence
of relaxed fiber (MgATP, pCa 8.2) at short and long sarcomere lengths,
respectively. All symbols are means SD. Note that at the short sarcomere
length (full filament overlap) fluorescence at low Ca2 concentrations
reaches a plateau that is about half-way between relaxing and saturating
Ca2 concentrations; i.e., fluorescence under rigor conditions does not
reach the relaxed level when Ca2 is reduced (Fig. 7 b). At long sarcomere
lengths, fluorescence at low Ca2 is independent on nucleotide (no cross-
bridge interaction with actin filaments, i.e., no interference of attached
cross-bridges with regulatory proteins). The lower fluorescence intensity at
the long sarcomere length results from the much reduced number of
fluorophores in the field of view.
FIGURE 9 (a) IANBD fluorescence at different Ca2 concentrations in
full filament overlap (; sarcomere length 2.4 m) and out of overlap (E;
sarcomere length 4.2 m). f, Active force versus pCa (in full filament
overlap). Fluorescence data are normalized to fluorescence observed in
overlap in the absence of Ca2. To illustrate the somewhat steeper profile
of fluorescence versus pCa in full filament overlap, in b fluorescence data
for both sarcomere lengths are normalized to their respective maximum
values under relaxing Ca2 concentrations. Data are from one representa-
tive fiber.
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imum fluorescence change (cf. Fig. 6; Rosenfeld and Tay-
lor, 1985). Second, in solution, saturating calcium alone or
attachment of strong binding cross-bridges at low Ca2
yields similar degrees of fluorescence change, while in
fibers attachment of strong binding cross-bridges at low
calcium gave only 50% of the maximum change seen at
saturating calcium.
The differences in behavior may have several potential
causes. One variable is the degree of labeling of components
other than troponin I during the labeling procedure. This
occurs because the labeling is done with the intact troponin-
tropomyosin complex (cf. Trybus and Taylor, 1980). We
observed that a small but significant (10%) fraction of the
tropomyosin and troponin C could be labeled during this
procedure. We separated the troponin from the tropomyosin
and reconstituted the regulated thin filaments for solution
studies with unlabeled tropomyosin. Therefore, in both our
fiber and solution experiments no fluorescence changes
could originate from fluorescently labeled tropomyosin. We
note that in our own solution studies done with the same
proteins used for the fiber studies we observed a better
agreement between solution and fiber studies. It is particu-
larly noteworthy that at low calcium concentrations the
addition of myosin subfragment 1 (S-1) without nucleotide
(rigor, strong binding state) gave only a 50% fluorescence
change in both solution and fibers. Fibers always give a
greater percentage inhibition of fluorescence with calcium
alone and even in two of seven of our solution experiments
we observed full inhibition of fluorescence with calcium
alone. At subsaturating calcium concentrations, however,
we do observe a further fluorescence decrease upon binding
to strong binding cross-bridges in the fibers. Additional
factors that affect calcium affinity or protein fluorescence
may be keys to qualitative differences between solution and
fiber studies. For instance, sarcomeric proteins not present
in solution studies may alter the calcium sensitivity in
addition to effects on the magnitude of the fluorescence
changes (e.g., 50% maximum change in fibers versus20%
in our solution studies). It is also possible that in solution
reconstitution either is incomplete or might involve (partial-
ly) denatured troponin molecules such that some regulated
units of the actin filaments do not respond to Ca2 and only
become activated by strong (e.g., rigor-like) cross-bridge
attachment.
The lack of further fluorescence change upon strong
cross-bridge attachment in the presence of saturating cal-
cium does not necessarily mean that Ca2 is sufficient to
achieve full activation of muscle fibers. It is possible that
further changes occur in the regulatory proteins upon strong
cross-bridge attachment that do not result in further changes
in TnI fluorescence. However, other work from our labora-
tory does suggest that Ca2 alone is sufficient to achieve
full or nearly full activation. For instance, diffusing N-ethyl
maleimide modified myosin subfragment 1 into skinned
fibers did not result in any further increase in the rate
constant of force redevelopment than that seen at saturating
Ca2 concentrations (Kraft et al., 1993). In addition, no
change in cross-bridge cycling kinetics (e.g., rate constant
of force redevelopment, ratio of ATPase over tension) was
observed when force generation was inhibited by the addi-
tion of caldesmon (Kraft et al., 1995a). A complete answer
to this question, however, will require additional experi-
ments with fluorescent probes on other sites of the regula-
tory system.
Fluorescence of IANBD-labeled TnI is not
sensitive to actin attachment of cross-bridges in
their weak binding states
From our previous work (e.g., Brenner et al., 1984, 1986,
1991; Kraft et al., 1995a) it is expected that under the
conditions of Fig. 7 c (MgATP at low Ca2, MgATPS at
low or high Ca2), i.e., when cross-bridges are in their weak
binding states, up to some 80% of all cross-bridges should
become attached to actin. Yet attachment of cross-bridges in
these weak binding states did not change the IANBD fluo-
rescence. We have made similar observations with weak
binding cross-bridge states formed in the presence of GTP
and AMPPNP (Heizmann et al., 1997). This is consistent
with the concept that attachment of cross-bridges in weak
binding states has little or no effect on the state of activation
of the regulated thin filament (Chalovich et al., 1983, Bren-
ner, 1987, 1990). Note that Morano and Ru¨egg (1991) did
observe a change in TnC-DANZ fluorescence with the
attachment of cross-bridges in their weak-binding states.
This observation will be tested using the exchange proce-
dure described in this work. The inability of weak binding
cross-bridges to activate the actin filament is independent of
experimental conditions (Chalovich et al., 1983). Therefore
the fluorescence of IANBD-labeled TnI is a useful probe for
distinguishing weak and strong binding states of the myosin
at subsaturating free Ca2, where sizable fluorescence
changes may occur.
There has been confusion over the terms “weak binding”
and “strong binding,” because the affinities of the various
myosin states are dependent on conditions such as ionic
strength. On the basis of the arguments already presented,
we propose to call the classical weak binding states of the
myosin head “nonactivating” states and the classical strong
binding states “activating.” Whether a myosin head is in one
of the activating or nonactivating states depends solely on
the nucleotide bound to the myosin head and is a property of
the myosin head that is independent of whether the myosin
head is dissociated from actin or bound to activated or
inactive forms of the actin filament.
Actin interaction of non activating (“weak
binding”) versus activating (“strong binding”)
states of the myosin head
Although the weak binding states of myosin do not activate
actin filaments (as the name “nonactivating” implies), they
are responsive to changes in Ca2. For example, the com-
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plex of myosin head and ATPS is a nonactivating state
with only a small Ca2 dependence on the affinity for
regulated actin. Yet Ca2 reduces the rate constants for
attachment and detachment of myosin-ATPS to and from
regulated actin by 50- and 100-fold, respectively (Kraft
et al., 1992). That same study showed that the affinity of the
myosin head for ATPS is reduced by up to 1000-fold when
the myosin-ATPS complex binds to regulated actin at high
Ca2-concentrations. Note that the large increase in actin
affinity as Ca2 concentration is raised, reported by others
(Dantzig et al., 1988), apparently was due to much reduced
ATPS saturation, i.e., to a large fraction of nucleotide-free
cross-bridges at high Ca2 concentrations (cf. Kraft et al.,
1992).
These findings suggested that even the nonactivating
(weak binding) states of myosin change their mode of
interaction with regulated actin when the tropomyosin-con-
trolled sites on actin become accessible at high Ca2, and
the following picture appears to emerge: in the absence of
Ca2, myosin heads in both the nonactivating (weak bind-
ing) and activating (strong binding) states bind only to sites
of electrostatic interaction. An increase in free Ca2
changes the average position of tropomyosin, exposing ad-
ditional sites for the interaction of myosin heads (Lehman et
al., 1994, 1995). As shown by the much slower actin bind-
ing kinetics and much reduced nucleotide affinity at high
Ca2 in the presence of ATPS, not only the activating
(strong binding) but also the nonactivating (weak binding)
states of the myosin head interact with these additional sites,
but in very different ways, e.g., resulting in different effects
of activation on affinities for nucleotide as well as for actin.
It appears that the presence of a -phosphate or -phosphate
analog dictates this different behavior, because other nucle-
otides or nucleotide analogs with an uncleaved (or only
slowly cleaved) -phosphate, e.g., MgAMPPNP or Mg-
GTP, show effects similar to those found with MgATPS
(Frisbie et al., 1997; Heizmann et al., 1997).
Geeves and co-workers have proposed, on the basis of
their studies, that nonactivating and activating states of
myosin pass through identical intermediates when interact-
ing with regulated actin (Geeves et al., 1984; McKillop and
Geeves, 1993). Such a concept becomes difficult to justify
when one now considers that Ca2 affects both activating
and nonactivating myosin states, but in very different ways.
We therefore favor the concept that binding of nonactivat-
ing and activating states of myosin to regulated actin occurs
through at least some different intermediates. Such dis-
tinctly different intermediates are consistent with current
structural data, which show that some structural changes in
the nucleotide binding pocket and in the catalytic domain
(specifically the position of loop2) are dependent on the
-phosphate moiety (Rayment et al., 1993; Fisher et al.,
1995; Smith and Rayment, 1995, 1996; Dominguez et al.,
1998). Thus, also in structural terms, an activating (strong
binding) state (no -phosphate, no -phosphate analog) may
not even transiently pass through an intermediate that is
equivalent to that with destabilized actin interaction (low
actin affinity) and destabilized nucleotide binding (very low
nucleotide affinity) that is seen when nonactivating myosin
states interact with both uncontrolled (electrostatic) and
tropomyosin-controlled binding sites on the Ca2-activated
thin filament.
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